OncoHost Proteomics Lab Earns CAP Accreditation
OncoHost’s CLIA-certified proteomics lab received CAP accreditation, emphasizing its commitment to precision-focused diagnostics for cancer.
Read MorePosted by Andy Lundin | Dec 3, 2024 | Cancer, Company News, Molecular Diagnostics |
OncoHost’s CLIA-certified proteomics lab received CAP accreditation, emphasizing its commitment to precision-focused diagnostics for cancer.
Read MorePosted by Andy Lundin | Nov 29, 2024 | Cancer, Miscellaneous, Point-of-Care |
The Center for Innovation and Translation of POC Technologies for Equitable Cancer Care showcased POC innovations for cancer detection.
Read MorePosted by Chris Wolski | Nov 28, 2024 | Breast |
A researcher’s new mouse model for studying breast cancer could enhance understanding of cancer metastasis and its spread to organs.
Read MorePosted by Andy Lundin | Nov 27, 2024 | Company News, Sepsis |
Trinity Biotech made a strategic investment in Novus Diagnostics to accelerate the development of a 15-minute bedside test for sepsis.
Read MorePosted by Andy Lundin | Nov 26, 2024 | Immunoassay Reagents & test Kits |
A biogel-based test uses bacteriophages to detect harmful bacteria in fluids quickly, accurately, and without the need for lab equipment.
Read More